Exits from the CMO industry are a more recent development that seems to be picking up momentum.
Jim Miller
Advertisement
Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.
Articles by Jim Miller
If R&D doesn't rebound, the growth prospects of R&D services providers will suffer, and even commercial CMOs will see fewer opportunities coming their way, writes Jim Miller.
Advertisement
Latest Updated Articles
R&D in TransitionJanuary 17th 2014
- The Shrinking CMO Industry
October 23rd 2014
Advertisement
Advertisement
Trending on PharmExec
1
Vinay Prasad Out at CBER for Second Time in Under a Year
2
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
3
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
4
Novo Nordisk Signs Deal with Hims & Hers
5